Rejuvenate/ABG II Hip Stems Overview

On July 6, 2012 the medical device manufacturer Stryker announced the recall of its Rejuvenate and ABG II modular-neck hip stems. These hip implant devices were intended to provide surgeons with an option to correct certain aspects of a patient’s anatomy and hip biomechanics. However, the high failure rate of the device coupled with the risks associated with fretting and corrosion at the modular neck junction forced Stryker to cease production and recall these devices. Patients have reported experiencing numerous side effects, including:

  • Loosening or dislocation of the hip joint
  • Tissue reactions at the site of neck junction
  • Development of pseudo-tumors around joint
  • Excess fluid in joint
  • Soft tissue necrosis
  • Severe pain and inflammation of the joint
  • Extensive muscle damage
  • Infection of joint
  • Metallosis

If you or a loved one has suffered any of these conditions after receiving a Rejuvenate or ABG II modular-neck hip stem, call our team of Stryker Rejuvenate and ABG II modular-neck hip stem lawyers to discuss your case.